Link copied to clipboard!

Marengo Asia Hospitals, Intermed Hospital join hands to establish cardiac centre in Mongolia

IMT News Desk
IMT News Desk
· 3 min read

Marengo Asia Hospitals will conduct comprehensive assessments and gap analysis at Intermed Hospital, facilitating training initiatives

The initiative is aimed at offering advanced treatments for cardiac health to the population of Mongolia, leveraging the pivotal role and expertise of the Marengo CIMS Cardiac Sciences team across various aspects of CoE collaboration.

Marengo Asia Hospital, India has entered into a multi-year agreement with Intermed Hospital, Mongolia under the concept of ‘Clinical Corridors’ to establish the first-ever comprehensive Cardiac Sciences Center of Excellence in Mongolia.

The initiative is aimed at offering advanced treatments for cardiac health to the population of Mongolia, leveraging the pivotal role and expertise of the Marengo CIMS Cardiac Sciences team across various aspects of CoE collaboration. This pioneering endeavour is a significant milestone for Marengo Asia Hospitals and will be spearheaded by Dr Raajiv Singhal, Managing Director & Group CEO, Marengo Asia Hospitals.

Dr Raajiv Singhal, MD and Group CEO, Marengo Asia Hospitals says, “Every life matters, every minute counts. Marengo Asia Hospitals is committed to elevating Intermed Hospital into a premier Cardiac Sciences Comprehensive Center of Excellence in Mongolia. This aims to provide the Mongolian population access to a wide range of surgeries including Angioplasties, Valve surgeries, EP Procedures, Triple Vessel to CABG surgeries, TAVI, and heart transplant surgeries.”

Under this collaboration, Marengo Asia Hospitals will conduct comprehensive assessments and gap analysis at Intermed Hospital, facilitating training initiatives, manpower allocation, equipment procurement, and dissemination of protocols covering various cardiac conditions such as chest pain, STEMI, and quality matrix adherence.

Nyamtogtokh Ya, Chief Executive Officer – Intermed Hospital, Mongolia says, “As Mongolia’s leading private hospital, Intermed Hospital is committed to addressing the most recognised health challenges, cardiovascular diseases, faced by our nation. We aim to develop a state-of-the-art Cardiology Center of Excellence as part of our mission to save lives and improve the health and well-being of the people of Mongolia. This Center will offer advanced treatments currently not widely available in our country. The partnership with Marengo Asia Hospital is a significant step towards realising the vision of better healthcare.”

Rajeev Taneja, MD & Founder of GlobalCare Consulting says, “GlobalCare Consulting specialises in expanding healthcare services internationally, building ‘medical corridors’. Mongolia sought to improve its healthcare excellence, and Global Care Consulting seamlessly facilitated this by identifying the need, conceptualising the model, and building the bridge, with our healthcare partner, Marengo Asia Hospital, willing to lead this initiative in the country with Intermed Hospital.”

 

Read Next

Cipla, Natco, Hetero and Annora Win Key Generic Drug Supply Contracts in China
Asia
November 12, 2025

Cipla, Natco, Hetero and Annora Win Key Generic Drug Supply Contracts in China

In a significant boost for India’s pharmaceutical exports, Cipla, Natco Pharma, Hetero Labs, and Annora Pharma have been selected by China under its volume-based procurement (VBP) program to supply essential generic medicines to public hospitals. The move marks a breakthrough for Indian drugmakers in gaining access to China’s tightly regulated healthcare market, which has traditionally […]
Article by: IMT News Desk
Gavi to boost access to life-saving human rabies vaccines in over 50 countries: Gavi, WHO and UAR
Asia
June 19, 2024

Gavi to boost access to life-saving human rabies vaccines in over 50 countries: Gavi, WHO and UAR

The first round of applications will be accepted by mid-July 2024 Gavi, the Vaccine Alliance, in collaboration with partners, is announcing support for human rabies vaccines for post-exposure prophylaxis (PEP) as part of routine immunisation. Eligible countries are receiving guidance on how to access these vaccines under Gavi’s cofinancing policy. The first round of applications […]
Article by: IMT News Desk
Takeda emphasises cross-sectoral alliances to address burden of vector-borne infectious diseases
Asia
December 19, 2023

Takeda emphasises cross-sectoral alliances to address burden of vector-borne infectious diseases

The AVPN South Asia Summit in December 2023 brought together social impact thought leaders and industry experts from South Asian countries Takeda Biopharmaceuticals India (formerly Baxalta Bioscience India) – a global values-based, R&D-driven biopharmaceutical leader – presented an industry perspective on the substantial need for vaccine equity and novel strategies for vector-borne disease financing at […]
Article by: IMT News Desk
Digital health ID not mandatory for accessing COVID vaccine: Health Ministry
Asia
October 21, 2020

Digital health ID not mandatory for accessing COVID vaccine: Health Ministry

According to the health ministry, in cases where beneficiaries do not have health IDs, other IDs can be utilised A digital health identity under the National Digital Health Mission (NDHM) will not be mandatory to get vaccinated when immunization against COVID-19 is available, the Union Health Ministry said. The ambitious NDHM programme was announced by […]
Article by: IMT News Desk